Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,275,194
+$139,602 QoQ
Shares Held
6,725
+16.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#612
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ellevest, Inc. holds $19,452,346 across 14 Drug Manufacturers - General names. AZN ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,180 | $3,814,187 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,926 | $3,074,491 | |
| 3 | JNJ |
Johnson & Johnson
|
50,449 | $2,009,847 | |
| 4 | NVS |
Novartis AG
|
12,495 | $1,958,216 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
6,725 | $1,275,194 | |
| 6 | PFE |
Pfizer Inc
|
45,568 | $1,097,277 | |
| 7 | AMGN |
Amgen Inc
|
2,956 | $1,070,426 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,309 | $1,049,759 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,275,194 | 6,725 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,135,592 | 5,758 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||